Pacer Advisors’s Aldeyra Therapeutics ALDX Stock Holding History

Pacer Advisors’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,810	Closed	-$45K	–	1403
2021 Q1	$45K	Buy	+3,810	New	+$43.9K	﹤0.01%	1449

Other funds holding ALDX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Pacer Advisors's ALDX Position: Q2 2021 in Review

Pacer Advisors sold out of Aldeyra Therapeutics (ALDX) in Q2 2021, closing a stake of 3,810 shares — an estimated $45K sold.

Pacer Advisors first reported a position in ALDX in Q1 2021 and held it in 1 quarter. The position peaked at $45K in Q1 2021. 136 funds tracked by Wall St. Rank hold ALDX as of Q2 2021.

Pacer Advisors reported no remaining Aldeyra Therapeutics position as of Q2 2021 after selling out during the quarter.
Pacer Advisors sold 3,810 Aldeyra Therapeutics shares in Q2 2021, an estimated $45K.
Pacer Advisors first reported a position in Aldeyra Therapeutics in Q1 2021 and held it in 1 quarter.
Pacer Advisors's Aldeyra Therapeutics position peaked at $45K in Q1 2021.
136 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2021.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.